Build capability,
not dependency.

Localisation should begin with the health need—not the equipment list.

Importing finished diagnostics can answer immediate demand, but it rarely builds enduring national capability. A well-designed localisation programme connects the target disease portfolio, expected demand, regulatory pathway, workforce, utilities, supply chain and quality system before equipment is selected.

For PCR and rapid-test production, this means defining what will be formulated, filled, assembled, packaged and released locally. For blood-grouping and medical-plastics programmes, it also means mapping component production, material control, clean environments, inspection, sterilisation or packaging requirements, and the validation strategy.

Technology transfer is a managed capability journey.

A production line alone does not transfer technology. Sustainable transfer combines process documentation, analytical methods, quality controls, training, supplier qualification, maintenance planning, traceability and change control. The local team must be able to operate, investigate, improve and expand the process after commissioning.

“The objective is not simply to reproduce an imported product. It is to establish a controlled local platform that can responsibly evolve.”

Local production creates strategic options.

When designed around realistic demand, local manufacturing can shorten replenishment routes, support faster portfolio adaptation, develop skilled employment and retain technical knowledge. It can also create a platform for regional supply. These benefits are not automatic: they depend on disciplined project governance, qualified processes, sustainable procurement and an achievable commercial model.

Infinity IVD’s localisation framework

1. Define the portfolio. Prioritise products using health need, addressable demand and regulatory feasibility.
2. Engineer the facility. Align layout, utilities, clean zones, material flow and biosafety with the intended process.
3. Integrate the production system. Specify equipment, tooling, automation, quality control and digital traceability as one architecture.
4. Transfer and qualify. Build documentation, training, validation and release readiness into commissioning.
5. Plan for continuity. Establish supplier strategy, critical spares, maintenance, local technical support and phased portfolio growth.

A call to investors and healthcare leaders

The right question is no longer only “What can we import?” It is “Which capabilities should we own, and how can we build them responsibly?” Infinity IVD works with public institutions, investors and healthcare companies to translate that question into a project definition, investment roadmap and executable facility programme.